• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.人源 SLC2A9a 和 SLC2A9b 异构体在己糖存在的情况下介导尿酸的电致转运,具有不同的特性。
Am J Physiol Renal Physiol. 2012 Aug 15;303(4):F527-39. doi: 10.1152/ajprenal.00134.2012. Epub 2012 May 30.
2
SLC2A9 is a high-capacity urate transporter in humans.SLC2A9 是人类中的一种高容量尿酸转运蛋白。
PLoS Med. 2008 Oct 7;5(10):e197. doi: 10.1371/journal.pmed.0050197.
3
Mouse GLUT9: evidences for a urate uniporter.小鼠葡萄糖转运蛋白9:尿酸单向转运体的证据
Am J Physiol Renal Physiol. 2009 Sep;297(3):F612-9. doi: 10.1152/ajprenal.00139.2009. Epub 2009 Jul 8.
4
Plasma urate level is directly regulated by a voltage-driven urate efflux transporter URATv1 (SLC2A9) in humans.在人类中,血浆尿酸水平由电压驱动的尿酸外流转运体URATv1(SLC2A9)直接调节。
J Biol Chem. 2008 Oct 3;283(40):26834-8. doi: 10.1074/jbc.C800156200. Epub 2008 Aug 13.
5
Solute carrier family 2, member 9 and uric acid homeostasis.溶质载体家族2成员9与尿酸稳态
Curr Opin Nephrol Hypertens. 2009 Sep;18(5):428-32. doi: 10.1097/MNH.0b013e32832ee3de.
6
Human sodium phosphate transporter 4 (hNPT4/SLC17A3) as a common renal secretory pathway for drugs and urate.人源磷酸钠转运蛋白 4(hNPT4/SLC17A3)作为药物和尿酸的共同肾脏分泌途径。
J Biol Chem. 2010 Nov 5;285(45):35123-32. doi: 10.1074/jbc.M110.121301. Epub 2010 Sep 1.
7
Genetic and Physiological Effects of Insulin-Like Growth Factor-1 (IGF-1) on Human Urate Homeostasis.胰岛素样生长因子-1(IGF-1)对人体尿酸稳态的遗传和生理影响。
J Am Soc Nephrol. 2023 Mar 1;34(3):451-466. doi: 10.1681/ASN.0000000000000054. Epub 2023 Jan 13.
8
Complex analysis of urate transporters SLC2A9, SLC22A12 and functional characterization of non-synonymous allelic variants of GLUT9 in the Czech population: no evidence of effect on hyperuricemia and gout.捷克人群中尿酸转运蛋白SLC2A9、SLC22A12的综合分析及GLUT9非同义等位基因变异的功能表征:无证据表明其对高尿酸血症和痛风有影响。
PLoS One. 2014 Sep 30;9(9):e107902. doi: 10.1371/journal.pone.0107902. eCollection 2014.
9
Facilitative glucose transporter 9, a unique hexose and urate transporter.易化葡萄糖转运蛋白 9,一种独特的己糖和尿酸转运蛋白。
Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E831-5. doi: 10.1152/ajpendo.00296.2009.
10
Human Mutations in SLC2A9 (Glut9) Affect Transport Capacity for Urate.SLC2A9(Glut9)基因的人类突变影响尿酸转运能力。
Front Physiol. 2018 Jun 18;9:476. doi: 10.3389/fphys.2018.00476. eCollection 2018.

引用本文的文献

1
Therapeutic effect and mechanism of gigantol on hyperuricemia.石斛酚对高尿酸血症的治疗作用及机制
Front Endocrinol (Lausanne). 2025 Jul 29;16:1474808. doi: 10.3389/fendo.2025.1474808. eCollection 2025.
2
Innovative modeling: a diet-induced quail model for progressive pathological changes in uric acid metabolism disorders.创新建模:一种用于尿酸代谢紊乱渐进性病理变化的饮食诱导鹌鹑模型。
Front Nutr. 2025 Jul 23;12:1612479. doi: 10.3389/fnut.2025.1612479. eCollection 2025.
3
Structural basis of disease mutation and substrate recognition by the human SLC2A9 transporter.人类SLC2A9转运蛋白疾病突变及底物识别的结构基础
Proc Natl Acad Sci U S A. 2025 Feb 18;122(7):e2418282122. doi: 10.1073/pnas.2418282122. Epub 2025 Feb 12.
4
Structural basis for urate recognition and apigenin inhibition of human GLUT9.尿酸识别和芹菜素抑制人 GLUT9 的结构基础。
Nat Commun. 2024 Jun 12;15(1):5039. doi: 10.1038/s41467-024-49420-9.
5
Identification of three distinct cell populations for urate excretion in human kidneys.鉴定人肾脏尿酸排泄的三种不同细胞群体。
J Physiol Sci. 2024 Jan 2;74(1):1. doi: 10.1186/s12576-023-00894-0.
6
Pharmacogenetics of sodium-glucose co-transporter-2 inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker.钠-葡萄糖共转运蛋白 2 抑制剂的药物遗传学:性别无关药效生物标志物的验证。
Diabetes Obes Metab. 2023 Dec;25(12):3512-3520. doi: 10.1111/dom.15246. Epub 2023 Aug 22.
7
Pathogenic Variants of (URAT1) and (GLUT9) in Spanish Patients with Renal Hypouricemia: Founder Effect of Variant c.374C>T; p.(T125M).西班牙肾性低尿酸血症患者的 (URAT1) 和 (GLUT9) 致病变体:变体 c.374C>T; p.(T125M) 的创始效应。
Int J Mol Sci. 2023 May 8;24(9):8455. doi: 10.3390/ijms24098455.
8
Pharmacogenetics of SGLT2 Inhibitors: Validation of a sex-agnostic pharmacodynamic biomarker.SGLT2 抑制剂的药物遗传学:一种性别不可知药效生物标志物的验证。
medRxiv. 2023 Jun 12:2023.03.07.23286875. doi: 10.1101/2023.03.07.23286875.
9
Therapeutic effects and mechanisms of N-(9,10-anthraquinone-2-ylcarbonyl) xanthine oxidase inhibitors on hyperuricemia.N-(9,10-蒽醌-2-基羰基)黄嘌呤氧化酶抑制剂对高尿酸血症的治疗作用及机制
Front Pharmacol. 2022 Sep 2;13:950699. doi: 10.3389/fphar.2022.950699. eCollection 2022.
10
Genetic and Physiological Effects of Insulin on Human Urate Homeostasis.胰岛素对人体尿酸稳态的遗传和生理影响。
Front Physiol. 2021 Aug 2;12:713710. doi: 10.3389/fphys.2021.713710. eCollection 2021.

本文引用的文献

1
Functional analysis of human sodium-phosphate transporter 4 (NPT4/SLC17A3) polymorphisms.人类磷酸钠转运蛋白 4(NPT4/SLC17A3)多态性的功能分析。
J Pharmacol Sci. 2011;115(2):249-53. doi: 10.1254/jphs.10228sc. Epub 2011 Jan 26.
2
Facilitative glucose transporter 9, a unique hexose and urate transporter.易化葡萄糖转运蛋白 9,一种独特的己糖和尿酸转运蛋白。
Am J Physiol Endocrinol Metab. 2009 Oct;297(4):E831-5. doi: 10.1152/ajpendo.00296.2009.
3
Glut9 is a major regulator of urate homeostasis and its genetic inactivation induces hyperuricosuria and urate nephropathy.Glut9是尿酸盐稳态的主要调节因子,其基因失活会导致高尿酸尿症和尿酸盐肾病。
Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15501-6. doi: 10.1073/pnas.0904411106. Epub 2009 Aug 21.
4
Mouse GLUT9: evidences for a urate uniporter.小鼠葡萄糖转运蛋白9:尿酸单向转运体的证据
Am J Physiol Renal Physiol. 2009 Sep;297(3):F612-9. doi: 10.1152/ajprenal.00139.2009. Epub 2009 Jul 8.
5
Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.鉴定出一种尿酸转运蛋白ABCG2,其具有导致痛风的常见功能多态性。
Proc Natl Acad Sci U S A. 2009 Jun 23;106(25):10338-42. doi: 10.1073/pnas.0901249106. Epub 2009 Jun 8.
6
Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations.对28141名个体进行的荟萃分析确定了五个新基因座中的常见变异,这些变异会影响尿酸浓度。
PLoS Genet. 2009 Jun;5(6):e1000504. doi: 10.1371/journal.pgen.1000504. Epub 2009 Jun 5.
7
In vitro-in vivo extrapolation of transporter-mediated clearance in the liver and kidney.肝脏和肾脏中转运体介导清除率的体外-体内外推法。
Drug Metab Pharmacokinet. 2009;24(1):37-52. doi: 10.2133/dmpk.24.37.
8
Mutations in glucose transporter 9 gene SLC2A9 cause renal hypouricemia.葡萄糖转运蛋白9基因SLC2A9的突变会导致肾性低尿酸血症。
Am J Hum Genet. 2008 Dec;83(6):744-51. doi: 10.1016/j.ajhg.2008.11.001. Epub 2008 Nov 20.
9
Mutations in the SLC2A9 gene cause hyperuricosuria and hyperuricemia in the dog.SLC2A9基因的突变会导致犬类出现高尿酸尿症和高尿酸血症。
PLoS Genet. 2008 Nov;4(11):e1000246. doi: 10.1371/journal.pgen.1000246. Epub 2008 Nov 7.
10
SLC2A9 is a high-capacity urate transporter in humans.SLC2A9 是人类中的一种高容量尿酸转运蛋白。
PLoS Med. 2008 Oct 7;5(10):e197. doi: 10.1371/journal.pmed.0050197.

人源 SLC2A9a 和 SLC2A9b 异构体在己糖存在的情况下介导尿酸的电致转运,具有不同的特性。

Human SLC2A9a and SLC2A9b isoforms mediate electrogenic transport of urate with different characteristics in the presence of hexoses.

机构信息

Membrane Protein Disease Research Group, Department of Physiology, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Am J Physiol Renal Physiol. 2012 Aug 15;303(4):F527-39. doi: 10.1152/ajprenal.00134.2012. Epub 2012 May 30.

DOI:10.1152/ajprenal.00134.2012
PMID:22647630
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3423118/
Abstract

Human SLC2A9 (GLUT9) is a novel high-capacity urate transporter belonging to the facilitated glucose transporter family. In the present study, heterologous expression in Xenopus oocytes has allowed us to undertake an in-depth radiotracer flux and electrophysiological study of urate transport mediated by both isoforms of SLC2A9 (a and b). Addition of urate to SLC2A9-producing oocytes generated outward currents, indicating electrogenic transport. Urate transport by SLC2A9 was voltage dependent and independent of the Na(+) transmembrane gradient. Urate-induced outward currents were affected by the extracellular concentration of Cl(-), but there was no evidence for exchange of the two anions. [(14)C]urate flux studies under non-voltage-clamped conditions demonstrated symmetry of influx and efflux, suggesting that SLC2A9 functions in urate efflux driven primarily by the electrochemical gradient of the cell. Urate uptake in the presence of intracellular hexoses showed marked differences between the two isoforms, suggesting functional differences between the two splice variants. Finally, the permeant selectivity of SLC2A9 was examined by testing the ability to transport a panel of radiolabeled purine and pyrimidine nucleobases. SLC2A9 mediated the uptake of adenine in addition to urate, but did not function as a generalized nucleobase transporter. The differential expression pattern of the two isoforms of SLC2A9 in the human kidney's proximal convoluted tubule and its electrogenic transport of urate suggest that these transporters play key roles in the regulation of plasma urate levels and are therefore potentially important participants in hyperuricemia and hypouricemia.

摘要

人类 SLC2A9(GLUT9)是一种新型的高容量尿酸转运蛋白,属于易化葡萄糖转运体家族。在本研究中,通过异源表达在非洲爪蟾卵母细胞中,我们能够对 SLC2A9(a 和 b)两种同工型介导的尿酸转运进行深入的示踪剂通量和电生理研究。尿酸的添加到产生 SLC2A9 的卵母细胞中产生外向电流,表明是电致转运。SLC2A9 的尿酸转运是电压依赖性的,与 Na+跨膜梯度无关。尿酸诱导的外向电流受细胞外 Cl-浓度的影响,但没有两种阴离子交换的证据。在非电压钳条件下进行的 [(14)C]尿酸通量研究表明,内流和外排具有对称性,表明 SLC2A9 主要在细胞电化学梯度的驱动下发挥尿酸外排作用。在存在细胞内己糖的情况下,尿酸的摄取在两种同工型之间表现出明显的差异,表明两种剪接变体之间存在功能差异。最后,通过测试一组放射性标记的嘌呤和嘧啶核苷碱基的转运能力来检查 SLC2A9 的可透性选择性。SLC2A9 介导除尿酸外的腺嘌呤摄取,但不能作为通用核苷碱基转运体发挥作用。SLC2A9 在人肾脏近曲小管中的两种同工型的差异表达模式及其对尿酸的电致转运表明,这些转运体在调节血浆尿酸水平方面发挥着关键作用,因此可能是高尿酸血症和低尿酸血症的重要参与者。